Cargando…

Clinical Implication of Patchy Pattern Corneal Staining in Dry Eye Disease

Corneal fluorescein staining in a form that is commonly called a “patchy pattern (PP)” is sometimes seen with or without superficial punctate keratopathy (SPK) in dry-eye diseases (DEDs). Here, we investigated the differences in the clinical features of DED patients with and without PP corneal stain...

Descripción completa

Detalles Bibliográficos
Autores principales: Komai, Seitaro, Yokoi, Norihiko, Kato, Hiroaki, Komuro, Aoi, Sonomura, Yukiko, Kinoshita, Shigeru, Sotozono, Chie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913618/
https://www.ncbi.nlm.nih.gov/pubmed/33546422
http://dx.doi.org/10.3390/diagnostics11020232
_version_ 1783656842507845632
author Komai, Seitaro
Yokoi, Norihiko
Kato, Hiroaki
Komuro, Aoi
Sonomura, Yukiko
Kinoshita, Shigeru
Sotozono, Chie
author_facet Komai, Seitaro
Yokoi, Norihiko
Kato, Hiroaki
Komuro, Aoi
Sonomura, Yukiko
Kinoshita, Shigeru
Sotozono, Chie
author_sort Komai, Seitaro
collection PubMed
description Corneal fluorescein staining in a form that is commonly called a “patchy pattern (PP)” is sometimes seen with or without superficial punctate keratopathy (SPK) in dry-eye diseases (DEDs). Here, we investigated the differences in the clinical features of DED patients with and without PP corneal staining (PPCS). This study involved 35 DEDs with PPCS (PPCS group) and 30 DEDs with SPK and without PPCS (non-PPCS group). The tear meniscus radius (TMR, mm), spread grade (SG) of the tear-film lipid layer (i.e., SG 1–5, 1 being best), noninvasive breakup time (NIBUT, seconds), fluorescein breakup time (FBUT, seconds), corneal epithelial damage (CED, 15 points maximum), conjunctival epithelial damage (CjED, six points maximum), the Schirmer’s 1 test (ST1, mm), and the prevalence of Sjögren’s syndrome (SS) were examined, and then compared between the two groups. Our findings revealed that between the groups (PPCS vs. non-PPCS), there was a statistically significant difference (p < 0.05) in CjED (3.1 ± 1.9 vs. 1.3 ± 1.6), ST1 (5.6 ± 7.4 vs. 14.8 ± 11.4), and the prevalence of SS (60.0% vs. 16.7%). Our findings suggest that DEDs and dry-eye patients with PPCS may indicate not only SS itself, but also the ophthalmological characteristics compatible with SS.
format Online
Article
Text
id pubmed-7913618
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79136182021-02-28 Clinical Implication of Patchy Pattern Corneal Staining in Dry Eye Disease Komai, Seitaro Yokoi, Norihiko Kato, Hiroaki Komuro, Aoi Sonomura, Yukiko Kinoshita, Shigeru Sotozono, Chie Diagnostics (Basel) Article Corneal fluorescein staining in a form that is commonly called a “patchy pattern (PP)” is sometimes seen with or without superficial punctate keratopathy (SPK) in dry-eye diseases (DEDs). Here, we investigated the differences in the clinical features of DED patients with and without PP corneal staining (PPCS). This study involved 35 DEDs with PPCS (PPCS group) and 30 DEDs with SPK and without PPCS (non-PPCS group). The tear meniscus radius (TMR, mm), spread grade (SG) of the tear-film lipid layer (i.e., SG 1–5, 1 being best), noninvasive breakup time (NIBUT, seconds), fluorescein breakup time (FBUT, seconds), corneal epithelial damage (CED, 15 points maximum), conjunctival epithelial damage (CjED, six points maximum), the Schirmer’s 1 test (ST1, mm), and the prevalence of Sjögren’s syndrome (SS) were examined, and then compared between the two groups. Our findings revealed that between the groups (PPCS vs. non-PPCS), there was a statistically significant difference (p < 0.05) in CjED (3.1 ± 1.9 vs. 1.3 ± 1.6), ST1 (5.6 ± 7.4 vs. 14.8 ± 11.4), and the prevalence of SS (60.0% vs. 16.7%). Our findings suggest that DEDs and dry-eye patients with PPCS may indicate not only SS itself, but also the ophthalmological characteristics compatible with SS. MDPI 2021-02-03 /pmc/articles/PMC7913618/ /pubmed/33546422 http://dx.doi.org/10.3390/diagnostics11020232 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Komai, Seitaro
Yokoi, Norihiko
Kato, Hiroaki
Komuro, Aoi
Sonomura, Yukiko
Kinoshita, Shigeru
Sotozono, Chie
Clinical Implication of Patchy Pattern Corneal Staining in Dry Eye Disease
title Clinical Implication of Patchy Pattern Corneal Staining in Dry Eye Disease
title_full Clinical Implication of Patchy Pattern Corneal Staining in Dry Eye Disease
title_fullStr Clinical Implication of Patchy Pattern Corneal Staining in Dry Eye Disease
title_full_unstemmed Clinical Implication of Patchy Pattern Corneal Staining in Dry Eye Disease
title_short Clinical Implication of Patchy Pattern Corneal Staining in Dry Eye Disease
title_sort clinical implication of patchy pattern corneal staining in dry eye disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913618/
https://www.ncbi.nlm.nih.gov/pubmed/33546422
http://dx.doi.org/10.3390/diagnostics11020232
work_keys_str_mv AT komaiseitaro clinicalimplicationofpatchypatterncornealstainingindryeyedisease
AT yokoinorihiko clinicalimplicationofpatchypatterncornealstainingindryeyedisease
AT katohiroaki clinicalimplicationofpatchypatterncornealstainingindryeyedisease
AT komuroaoi clinicalimplicationofpatchypatterncornealstainingindryeyedisease
AT sonomurayukiko clinicalimplicationofpatchypatterncornealstainingindryeyedisease
AT kinoshitashigeru clinicalimplicationofpatchypatterncornealstainingindryeyedisease
AT sotozonochie clinicalimplicationofpatchypatterncornealstainingindryeyedisease